• Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure

    Monday July 10th 2023

  • VIB researchers uncover key genetic pathway in leaf development

    Tuesday July 4th 2023

  • Benoît van Den Hove steps up as new CEO of Euronext Brussels

    Tuesday July 4th 2023

  • KU Leuven research generates new insights into the development of and care for 'the little brain' of the gut

    Monday July 3rd 2023

  • AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software

    Monday July 3rd 2023

  • argenx and Zai Lab announce approval of VYVGART® (efgartigimod alfa injection) for generalized myasthenia gravis in China

    Friday June 30th 2023

  • Flen Health receives 1.7 million grant from VLAIO for groundbreaking research on recombinant engineering of wound-healing enzymes

    Monday June 26th 2023

  • argenx announces U.S. Food and Drug Administration approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in generalized myasthenia gravis

    Wednesday June 21st 2023

  • Your news here?

  • argenx initiates second cohort of Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy

    Tuesday June 20th 2023

  • Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards

    Friday June 16th 2023

  • With the platform Startup.Flanders, Flanders claims its place among international start-up ecosystems

    Friday June 16th 2023

Strategic Partners